• Home
  • NEW DAY MEDICINE
  • 12 (86) 2025
  • 7 -12 (86) 2025 - Ashurov F.Z. - PROGNOSTIC MARKERS IN THE DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH METABOLIC SYNDROME

7 -12 (86) 2025 - Ashurov F.Z. - PROGNOSTIC MARKERS IN THE DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH METABOLIC SYNDROME

PROGNOSTIC MARKERS IN THE DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH METABOLIC SYNDROME

Ashurov F.Z. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Resume

Obstructive Sleep Apnea (OSA) syndrome is a common breathing disorder characterized by recurrent episodes of partial or complete upper airway obstruction during sleep. According to the World Health Organization, approximately 1 billion people worldwide suffer from OSA, which results in significant socio-economic damage (Senaratna et al., 2017). Metabolic Syndrome (MetS), which includes obesity, hypertension, dyslipidemia, and impaired glucose metabolism, plays a major role in its risk structure. Studies show that patients with MetS have a 2-3 times higher risk of developing OSA compared to individuals without metabolic disorders (Peppard et al., 2013). The differentiation and timely treatment of obstructive sleep apnea require the use of modern diagnostic methods, among which functional diagnostic markers are of particular importance. They allow not only for diagnosing the disease but also for predicting its course, assessing the effectiveness of therapy, and preventing the development of complications.

Keywords: Obstructive Sleep Apnea (OSA), Metabolic Syndrome (MetS), obesity, hypertension, dyslipidemia.

First page

34

Last page

37

For citation:Ashurov F.Z. - PROGNOSTIC MARKERS IN THE DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA IN PATIENTS WITH METABOLIC SYNDROME//New Day in Medicine 12(86)2025 34-37 https://newdayworldmedicine.com/en/new_day_medicine/12-86-2025

List of References

  1. Senaratna C. V., Perret J. L., Lodge C. J., et al. (2017). Prevalence of Obstructive Sleep Apnea in the General Population: A Systematic Review. Sleep Medicine Reviews, 2017;34:70-81. https://doi.org/10.1016/j.smrv.2016.07.006
  2. Peppard P. E., Szklo-Coxe M., Hla K. M., et al. (2013). Longitudinal Study of Relation of Obstructive Sleep Apnea and Blood Pressure. American Journal of Respiratory and Critical Care Medicine, 2013;187(10):1172-1179. https://doi.org/10.1164/rccm.201212-2192OC
  3. Tasali E., Leproult R., Van Cauter E. (2008). Sleep-Disordered Breathing and the Current Epidemic of Metabolic Disorder and Obesity. // Sleep 2008;31(4):453–456. https://doi.org/10.5665/sleep.7554
  4. Kushida C.A., Littner M.R., Morgenthaler T., et al. (2011). Practice parameters for the indications for polysomnography and related procedures: An update for 2005. // Sleep 2011;28(4):499–521. https://doi.org/10.1093/sleep/28.4.499
  5. Ip R., Tudor-Smith, C., Bittar R. (2010). Sleep apnea and cardiovascular disease: Is there a link? Current Treatment Options in Cardiovascular Medicine, 2010;12(4):372-381. https://doi.org/10.1007/s11936-010-0077-4
  6. McNicholas W.T., Bonsignore M.R. (2018). Sleep apnea as an independent risk factor for cardiovascular disease: Current evidence, basic mechanisms, and research priorities. // European Respiratory Journal 2018;52(2):1702314. https://doi.org/10.1183/13993003.02314-2017
  7. Ip M. S., Lam B., Ng V., et al. (2007). Obstructive sleep apnea is independently associated with insulin resistance. // European Respiratory Journal 2007;29(3):469-474. https://doi.org/10.1183/09031936.00152506
  8. Yaggi H. K., Concato J., Kern R. L., et al. (2005). Obstructive sleep apnea as a risk factor for stroke and death. // New England Journal of Medicine 2005;353(19):2034-2041. https://doi.org/10.1056/NEJMoa043436

    file

    download